Reticulocyte: Difference between revisions

Jump to navigation Jump to search
 
(One intermediate revision by one other user not shown)
Line 39: Line 39:
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
| '''Drug Side Effect'''
| '''Drug Side Effect'''
|bgcolor="Beige"| [[Antimetabolite]] medication, [[Chemotherapy]], Chronic [[alcoholism]], [[Drug induced anemia]], Drug induced [[bone marrow suppression]], [[Methotrexate]] ([[Rheumatrex]])
|bgcolor="Beige"| [[Antimetabolite]] medication, [[Chemotherapy]], Chronic [[alcoholism]], [[Drug induced anemia]], Drug induced [[bone marrow suppression]], [[Methotrexate]] ,[[Olsalazine]], ([[Rheumatrex]])
|-
|-
|-bgcolor="LightSteelBlue"
|-bgcolor="LightSteelBlue"
Line 133: Line 133:
|bgcolor="Beige"| [[Lead poisoning]], Tetraethyl lead poisoning
|bgcolor="Beige"| [[Lead poisoning]], Tetraethyl lead poisoning
|-
|-
|}  
|}


===In Alphabetical Order===
===In Alphabetical Order===
Line 240: Line 240:
==References==
==References==
{{Reflist|2}}
{{Reflist|2}}
{{Blood}}
[[es:Reticulocito]]
[[es:Reticulocito]]
[[fr:Réticulocyte]]
[[fr:Réticulocyte]]

Latest revision as of 21:30, 23 February 2015

Reticulocyte
Peripheral blood; Reticulocyte.
© Image courtesy of Nivaldo Medeiros MD and published with permission

WikiDoc Resources for Reticulocyte

Articles

Most recent articles on Reticulocyte

Most cited articles on Reticulocyte

Review articles on Reticulocyte

Articles on Reticulocyte in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Reticulocyte

Images of Reticulocyte

Photos of Reticulocyte

Podcasts & MP3s on Reticulocyte

Videos on Reticulocyte

Evidence Based Medicine

Cochrane Collaboration on Reticulocyte

Bandolier on Reticulocyte

TRIP on Reticulocyte

Clinical Trials

Ongoing Trials on Reticulocyte at Clinical Trials.gov

Trial results on Reticulocyte

Clinical Trials on Reticulocyte at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Reticulocyte

NICE Guidance on Reticulocyte

NHS PRODIGY Guidance

FDA on Reticulocyte

CDC on Reticulocyte

Books

Books on Reticulocyte

News

Reticulocyte in the news

Be alerted to news on Reticulocyte

News trends on Reticulocyte

Commentary

Blogs on Reticulocyte

Definitions

Definitions of Reticulocyte

Patient Resources / Community

Patient resources on Reticulocyte

Discussion groups on Reticulocyte

Patient Handouts on Reticulocyte

Directions to Hospitals Treating Reticulocyte

Risk calculators and risk factors for Reticulocyte

Healthcare Provider Resources

Symptoms of Reticulocyte

Causes & Risk Factors for Reticulocyte

Diagnostic studies for Reticulocyte

Treatment of Reticulocyte

Continuing Medical Education (CME)

CME Programs on Reticulocyte

International

Reticulocyte en Espanol

Reticulocyte en Francais

Business

Reticulocyte in the Marketplace

Patents on Reticulocyte

Experimental / Informatics

List of terms related to Reticulocyte

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-In-Chief: Varun Kumar, M.B.B.S. [2]

Overview

Reticulocytes are immature red blood cells, typically composing about 1% of the red cells in the human body. Reticulocytes develop and mature in the red bone marrow and then circulate for about a day in the blood stream before developing into mature red blood cells. Like mature red blood cells, reticulocytes do not have a cell nucleus. They are called reticulocytes because of a reticular (mesh-like) network of ribosomal RNA that becomes visible under a microscope with certain stains such as new methylene blue.

Differential Diagnosis of Reticulocytosis

An elevation in the number of reticulocytes is called reticulocytosis. There are numerous causes of reticulocytosis.

By Organ System

Cardiovascular No underlying causes
Chemical / poisoning No underlying causes
Dermatologic No underlying causes
Drug Side Effect Antimetabolite medication, Chemotherapy, Chronic alcoholism, Drug induced anemia, Drug induced bone marrow suppression, Methotrexate ,Olsalazine, (Rheumatrex)
Ear Nose Throat No underlying causes
Endocrine Addison's disease (chronic adrenal insufficiency), Adrenocorticoid (Isolated) Deficiency, androgen deficiency, Hypogonadism, Hypothyroidism (myxedema)
Environmental No underlying causes
Gastroenterologic Liver disease/Liver disorders
Genetic Klinefelter's syndrome
Hematologic Acquired sideroblastic anemia, Acute Myelogenous/Blastic Leukemia AML, Anemia of chronic disease, Anemia of uremia, Aplastic anemia, congenital aplastic anemia, congenital folate malabsorption, Fanconi's pancytopenia-dysmelia syndrome, Folate depletion, Folic acid deficiency anemia, Hemoglobin H disease, Hereditary elliptocytosis, Hereditary sideroblastic anemia, Iron deficiency anemia, Leukemia, Lymphoma/malignant, Megaloblastic anemia, Megaloblastic anemia of pregnancy, Myelophthisic anemia, Myeloproliferative disease, non-Hodgkins lymphoma, Pellagra/niacin deficiency, Pernicious anemia, Primary Myelofibrosis/Myeloid metaplasia, Sideroblastic anemia-Siderochrestic, Refractory megaloblastic anemia, Secondary myelofibrosis, Thalassemia major, Thalassemia minor, Thalassemia-hemoglobin C disease, Vitamin B12 deficiency
Iatrogenic No underlying causes
Infectious Disease Abscesses, Bacteremia/Septicemia, Infected organ, Parvovirus Infection/Parvovirus B19, Posthepatitic aplastic anemia, Tuberculosis of bone marrow
Musculoskeletal / Ortho No underlying causes
Neurologic No underlying causes
Nutritional / Metabolic Anemia of malnutrition, Anemia of uremia, Folate depletion, Folic acid deficiency anemia, Folic acid dependency/metabolic defect, Impaired folic acid metabolism, Inadequate Folic acid in diet, Iron deficiency anemia, Iron deficient diet, Kwashiorkor (protein deficiency,severe), Malnutrition/Starvation, Malabsorption of folic acid, Megaloblastic anemia of pregnancy Pellagra/niacin deficiency, Vitamin B12 deficiency
Obstetric/Gynecologic Megaloblastic anemia of pregnancy
Oncologic Acute Myelogenous/Blastic Leukemia AML, Leukemia, Lymphoma/malignant, Myeloproliferative disease, non-Hodgkins lymphoma, Primary Myelofibrosis/Myeloid metaplasia
Opthalmologic No underlying causes
Overdose / Toxicity Antimetabolite medication, Chronic alcoholism, Chemotherapy, Drug induced anemia, Drug induced bone marrow suppression, Methotrexate (Rheumatrex)
Psychiatric No underlying causes
Pulmonary No underlying causes
Renal / Electrolyte Anemia of uremia, Chronic renal failure
Rheum / Immune / Allergy No underlying causes
Sexual Hypogonadism
Trauma No underlying causes
Urologic No underlying causes
Miscellaneous Lead poisoning, Tetraethyl lead poisoning

In Alphabetical Order

Diagnosis

Laboratory Findings

  • Reticulocytes appear slightly bluer than other red cells when looked at with the normal Romanowsky stain.
  • Reticulocytes are also slightly larger, which can be picked up as a high MCV (mean corpuscular volume) with a full blood count done by a trained medical scientist, who has specialized in haematology, or a machine. [1] [2] [3]
  • The reticulocyte count is the percentage of circulating red blood cells that are in the reticulocyte stage.
  • To accurately measure reticulocyte counts, automated counters that use lasers mark cell samples with fluorescent dye that marks RNA and DNA (such as thiazole orange).[4]
  • This distinguishes reticulocytes as the middle ground of dye response to laser light, between red blood cells (which have neither RNA nor DNA) and lymphocytes (which have a large amount of DNA, unlike reticulocytes).[5]
  • The normal range of values for reticulocytes in the blood depends on the clinical situation and the lab, but broadly speaking is 0.5% to 1.5%.
  • However, if a person has anaemia, their reticulocyte percentage should be higher than "normal" if the bone marrow's ability to produce new blood cells remains intact.
  • Thus, calculating the reticulocyte production index is an important step in understanding whether the reticulocyte count is appropriate or inappropriate to the situation.
  • This is often a more important question than whether the percentage is in the normal range; for instance, if someone is anemic but only has a reticulocyte percentage of 1%, this means that the bone marrow is likely not producing new blood cells at a rate that will correct the anemia.
  • The number of reticulocytes is a good indicator of bone marrow activity, because it represents recent production.
  • This means that the reticulocyte count, and the reticulocyte production index that can be calculated from it, can be used to determine whether a production problem is contributing to the anaemia, and can also be used to monitor the progress of treatment for anaemia.
  • The specimen requirement for a reticulocyte count is EDTA anti-coagulated whole blood (lavender-top bottle if using the Vacutainer®, Vacuette® or Monoject® systems; red-top if using the S-Monovette® system).
  • When there is an increased production of red blood cells to overcome chronic or severe loss of mature red blood cells, such as in a haemolytic anaemia, people often have a markedly high number and percentage of reticulocytes.
  • A very high number of reticulocytes in the blood can be described as reticulocytosis.
  • Abnormally low numbers of reticulocytes can be attributed to chemotherapy, aplastic anaemia, pernicious anaemia, bone marrow malignancies, problems of erythropoietin production, or other causes of anaemia due to poor RBC production.

Related Chapters

References

  1. The Disease Database
  2. Sailer, Christian, Wasner, Susanne. Differential Diagnosis Pocket. Hermosa Beach, CA: Borm Bruckmeir Publishing LLC, 2002:77 ISBN 1591032016
  3. Kahan, Scott, Smith, Ellen G. In A Page: Signs and Symptoms. Malden, Massachusetts: Blackwell Publishing, 2004:68 ISBN 140510368X
  4. Davis BH, Bigelow NC (1994). "Reticulocyte analysis and reticulocute maturity index". In Darzynkiewicz Z, Crissman HA (eds.). Flow cytometry. Methods in Cell Biology. 42. San Diego: Academic Press. pp. 263&ndash, 74. ISBN 0-12203-052-4.
  5. http://www.medicaldesign.com/articles/ID/532

he:רטיקולוציט id:Retikulosit fi:Retikulosyytti sq:Retikulociti


Template:WikiDoc Sources